US Urinalysis Market (2024-2029)
The US Urinalysis Market was valued at $916.8 Million in 2024 and projected to reach to $1438.1 Million by 2029, representing a compound annual growth rate of 9.4%. The US urinalysis market is poised for sustained expansion through 2029, supported by increasing healthcare spending and technological advancements in diagnostic testing.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
US Urinalysis Market Trends and Insights
- This expansion reflects increasing demand for diagnostic testing across US healthcare facilities, driven by rising prevalence of chronic diseases and growing adoption of point-of-care testing solutions.
- The US market benefits from advanced healthcare infrastructure, high reimbursement rates, and strong regulatory frameworks that support innovation in diagnostic technologies. In the US, urinalysis remains a cornerstone of routine clinical assessment and disease screening.
- Between 2024 and 2029, the US market will be propelled by technological advancements in automated urinalysis systems, integration of artificial intelligence in result interpretation, and expanding applications in preventive healthcare.
- The US healthcare sector's emphasis on early disease detection and personalized medicine continues to create sustained demand for reliable urinalysis platforms. The US urinalysis market's 9.4% compound annual growth rate underscores the region's commitment to modernizing diagnostic capabilities.
- Key drivers include aging demographics in the US, increased screening initiatives, and growing laboratory automation investments that enhance testing efficiency and accuracy across US clinical settings..
Key Market Statistics
- CAGR (2024-2029) 9.4% CAGR
- Market Size, 2024 ~USD 916.8 Million
- Forecast, 2029 ~USD 1438.1 Million
- Country US
US Urinalysis Market Overview
Market Valuation :
The US urinalysis market is valued at $916.8 million in 2024, with strong growth trajectory reaching $1,438.1 million by 2029, representing a 9.4% CAGR.
Point-of-Care Testing Adoption :
US healthcare facilities are increasingly adopting point-of-care urinalysis testing solutions, driven by demand for faster diagnostic results and improved patient outcomes in clinical settings.
Chronic Disease Prevalence :
Rising prevalence of chronic diseases such as diabetes, hypertension, and kidney disorders across the US population is driving sustained demand for routine urinalysis screening and monitoring.
Advanced Healthcare Infrastructure :
The US benefits from sophisticated healthcare infrastructure, including well-established laboratory networks, digital health integration, and high adoption rates of automated urinalysis systems.
US Urinalysis Market Dynamics
- Growing awareness of preventive healthcare and early disease detection is driving adoption across hospitals, diagnostic laboratories, and outpatient clinics nationwide.
- The shift toward point-of-care testing and automation is enhancing efficiency and accessibility of urinalysis services. Key growth drivers include the rising burden of chronic diseases, aging population demographics, and integration of AI-powered diagnostic tools in US healthcare systems.
- Regulatory support for advanced diagnostic technologies and reimbursement policies favoring urinalysis testing further strengthen market prospects.
- Strategic investments by major healthcare providers and diagnostic companies will continue to accelerate market penetration across diverse US healthcare settings..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- The US urinalysis market will grow from $916.8M (2024) to $1,438.1M (2029) at a 9.4% CAGR.
- Automation and AI integration are transforming US urinalysis testing capabilities and clinical workflows.
- The US market is driven by chronic disease prevalence, aging populations, and preventive healthcare initiatives.
- Advanced healthcare infrastructure and favorable reimbursement policies support sustained US market expansion.
Urinalysis Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | HOSPITALS & CLINICS (End User) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 9.6% from 2024 to 2029 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 4.3 (2024) |
| Revenue Forecast (Billions) | ~USD 6.8 (2029) |
| Segments Covered | Product, Type, Test Type, Application, End User |
US Urinalysis Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Type
- Automated Urine Analyzers
- Biochemical Urine Analyzers
- Brazil
- Diabetes
- Dipsticks
- Disposables
- Flow Cytometry Analyzers
- Integrated Urine Analyzers
- Kidney Diseases
- Laboratory Tests
- Liver Diseases
- Mexico
- Microscopy Analyzers
- Other Disease Screening Applications
- Poc Tests
- Point-Of-Care Urine Analyzers
- Pregnancy & Fertility Kits
- Reagents
- Rest Of Latam
- Sediment Urine Analyzers
- Semi-Automated Urine Analyzers
- Urinary Tract Infections
By Test Type
- Biochemical Tests
- Pregnancy & Fertility Tests
- Sediment Urinalysis
By Application
- Disease Screening
- Pregnancy & Fertility Testing
By End User
- Diagnostic Laboratories
- Home Care Settings
- Hospitals & Clinics
- Research Laboratories & Institutes
US: URINALYSIS MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| DIAGNOSTIC LABORATORIES | 407.7 | 423.9 | 445.3 | 471.3 | 502.6 | 541.7 | 589.7 | 648.8 | 7.8 |
| HOME CARE SETTINGS | 330.3 | 344.4 | 363.1 | 385.7 | 413 | 447.2 | 489.3 | 541.3 | 8.3 |
| HOSPITALS & CLINICS | 360.7 | 386 | 417.5 | 455.3 | 500.4 | 556.2 | 624.8 | 709.6 | 11.2 |
| RESEARCH LABORATORIES & INSTITUTES | 80.6 | 82.9 | 86.1 | 90.3 | 95.3 | 101.8 | 109.8 | 119.9 | 6.8 |
| TOTAL | 1179.3 | 1237.2 | 1312.1 | 1402.6 | 1511.2 | 1647 | 1813.7 | 2019.7 | 9 |
Target Audience
- Diagnostic Equipment Manufacturers : Need comprehensive US market data to benchmark product positioning, identify growth opportunities in point-of-care testing, and develop sales strategies for automated urinalysis systems across American healthcare facilities.
- Healthcare Laboratory Operators : Require market insights to optimize service offerings, assess competitive threats, plan capital investments in urinalysis technology, and understand reimbursement trends specific to US laboratory operations.
- Medical Device Investors & PE Firms : Need validated US market sizing and growth forecasts to evaluate investment opportunities, assess portfolio company performance, and make informed decisions on acquisitions within the American diagnostics sector.
- Hospital & Healthcare System Administrators : Seek market intelligence to justify budget allocations for urinalysis infrastructure upgrades, benchmark operational efficiency against industry standards, and plan procurement strategies for diagnostic solutions.
- Market Research & Strategy Consultants : Require detailed US-specific market data, growth drivers, and competitive landscape analysis to support client advisory engagements, strategic planning, and market opportunity assessments in healthcare diagnostics.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise US market valuation ($916.8M in 2024) and verified 5-year forecast data to support investment decisions, business planning, and competitive positioning in the American urinalysis sector.
- Regional Demand Insights : Understand US-specific drivers including chronic disease prevalence, healthcare infrastructure maturity, and point-of-care adoption trends that differentiate the American market from global competitors.
- Strategic Market Entry : Leverage detailed US market analysis to identify optimal entry points, assess competitive landscape, and develop targeted go-to-market strategies for diagnostic companies and healthcare technology providers.
- Investment & Funding Decisions : Access credible market data and growth projections (9.4% CAGR) to support venture capital pitches, acquisition valuations, and capital allocation decisions within the US healthcare diagnostics space.
- Regulatory & Reimbursement Strategy : Gain insights into US-specific regulatory environment, reimbursement policies, and healthcare infrastructure factors that influence market dynamics and profitability for urinalysis solution providers.
Frequently asked questions
What is the current size of the US urinalysis market?
The US urinalysis market was valued at $916.8 million in 2024 and is expected to reach $1,438.1 million by 2029.
What is the projected growth rate for the US urinalysis market?
The US urinalysis market is projected to grow at a compound annual growth rate (CAGR) of 9.4% from 2024 to 2029.
What factors are driving growth in the US urinalysis market?
Key drivers include rising chronic disease prevalence, aging demographics, increased adoption of automated testing systems, AI integration, and growing emphasis on preventive healthcare in the US.
How is technology impacting the US urinalysis market?
Technological advancements such as automated urinalysis systems, artificial intelligence-powered result interpretation, and point-of-care testing solutions are enhancing efficiency and accuracy across US laboratories.
What role does reimbursement play in the US urinalysis market?
Favorable reimbursement rates and strong regulatory frameworks in the US support market expansion by incentivizing healthcare providers to invest in advanced urinalysis technologies and testing capabilities.
RESEARCH METHODOLOGY
The objective of this study is to analyze the key market dynamics, including drivers, opportunities, constraints, challenges, and strategies employed by key players. Developments within companies, such as acquisitions, product launches, expansions, agreements, and partnerships, will be tracked to assess the competitive landscape of the urinalysis market. This analysis will evaluate market players across various parameters within the broader categories of business and product strategy.
To estimate the market size, both top-down and bottom-up approaches were used. The market breakdown and data triangulation were used to determine the sizes of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources, including annual reports, press releases and investor presentations from companies, white papers, certified publications, articles by recognized authors, gold- and silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva), were consulted to identify and collect information for this study.
Primary Research
In the primary research process, interviews with sources from both the supply and demand sides were conducted to gather qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with key industry participants, subject-matter experts, C-level executives at key market players, and industry consultants to obtain and verify critical qualitative and quantitative information and to assess prospects.
Note 1: Other designations include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
|
COMPANY NAME |
DESIGNATION |
|
Sysmex Corporation |
Sales Manager |
|
Thermo Fisher Scientific, Inc. |
Sales Executive |
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the urinalysis market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research.
- The revenue generated by leading players operating in the urinalysis market was determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After determining the overall market size using the process described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.
Market Definition
Urinalysis is a procedure used to assess the appearance, concentration, and content of urine. It detects and helps manage various disorders, such as urinary tract infections, kidney diseases, diabetes, and other metabolic disorders. The primary urinalysis tests include biochemical and sediment analysis. In this report, we have also discussed pregnancy and fertility tests for urine analysis.
Key Stakeholders
- Manufacturers and Distributors of Urinalysis Products
- Hospitals & Clinics
- Diagnostic Laboratories
- Research Laboratories & Institutes
- Research & Development (R&D) Companies
- Government Associations
- Venture Capitalists and Investors
Report Objectives
- To define, segment, and forecast the urinalysis market by product, test type, application, technology, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
- To study the impact of AI on the market, along with the macroeconomic outlook for each region
Available customizations:
MarketsandMarkets offers the following customizations for this market report.
Country Information
- Additional country-level analysis of the urinalysis market
Company profiles
- Additional five company profiles of players operating in the urinalysis market.
Product Analysis
- Product matrix, which provides a detailed comparison of the product portfolio of each company in the urinalysis market
Get the Full Urinalysis Market Report
Full forecast, segment splits, and company analysis for all Urinalysis Market.
- Canada Urinalysis Market
- Germany Urinalysis Market
- UK Urinalysis Market
- France Urinalysis Market
- Italy Urinalysis Market
- Spain Urinalysis Market
- Russia Urinalysis Market
- China Urinalysis Market
- Japan Urinalysis Market
- India Urinalysis Market
- Australia Urinalysis Market
- South Korea Urinalysis Market
- Brazil Urinalysis Market
- Mexico Urinalysis Market
- Rest Of Europe Urinalysis Market
- Rest Of Asia Pacific Urinalysis Market
- Rest Of Latin America Urinalysis Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
